About Us

Innovation and Experience

Building on an unparalleled breadth of technology and the expertise gained in nearly forty years of automating laboratory processes, STRATEC has established itself as one of the world’s leading providers of automation solutions for in-vitro diagnostics and life science companies.

We have consistently extended our business model and aligned it ever more closely to the needs of our partners. That is why in addition to pure instrumentation we now cover virtually the entire value chain for the specification, design, manufacture and approval of complex analyzer system solutions – developing and integrating complex consumables, instrumentation and complementary middleware laboratory software.

We have always been an early mover when it comes to seizing new technologies and applications and integrating these into our existing technology portfolio, whether by way of proprietary development work or in partnership with our customers.

Our Values


As the innovative and technological market leader for automation and instrumentation solutions in in vitro diagnostics, we seek to offer our worldwide partners first class solutions and thereby share responsibility toward their customers and patients.

Our success is based on the talents and skills of our employees and their commitment to always perform the extraordinary. Their performance allows for the successful and sustainable development of our company in the interest of all its stakeholders.

Our partnerships are built on mutual trust, continuity and professionalism and with our partners we share a common mission to develop safe, innovative, market-leading products that consistently fulfill customer expectations. For STRATEC, partnership means responsibility, passion and commitment, to both our customers and our products, that goes well beyond the duration of the product life cycle.

Since its inception, STRATEC has embraced a personal responsibility towards its people, the community and the environment. This philosophy continues to guide the day-to-day work of employees and STRATEC maintains close links to local and regional communities and their administrative structures. Sustainable and responsible entrepreneurial action remain a key priority at our company.

In 2014, STRATEC published its first CSR Report detailing its organizational goals and sustainable activities:

STRATEC is a major employer for many citizens in the area around its Birkenfeld headquarters and other areas in which the divisions operate. STRATEC has worked very closely with regional suppliers and local tradesmen to demonstrate its commitment and become an integral part of these communities. These efforts are viewed as core components of sustainable business success. This creates a sense of personal responsibility towards our people and our environment, one that is the basis of our day-to-day work. Structures evolve as a result, and these are then lived and mapped onto other locations.

For inquiries regarding STRATEC’s Corporate Sustainability Policy, please contact sustainability@stratec.com

STRATEC Succeeds When its Partners Succeed

The STRATEC Group is committed to continually enhancing its processes and service quality. One of STRATEC’s fundamental obligations is to structure its business processes so that it and its partners – diagnostics and life science companies operating in highly regulated worldwide markets – meet regulatory and legal requirements in a continually changing environment. STRATEC’s commitment to satisfy regulatory standards enhances its partners’ positions in their respective markets.

STRATEC’s success is derived from the economic viability of its partners. Clearly defined processes throughout the value chain, from the initial development steps through to serial production, play a crucial role in safeguarding permanent market success. At the same time, a flexible quality management system also facilitates compliance with the necessary international requirements enabling STRATEC to work together with its OEM partners to access new markets rapidly and efficiently.

STRATEC’s complaint handling system supports the service and vigilance process – as well as its partners’ risk management – by offering interdisciplinary error analyses and risk assessments. Additionally, STRATEC actively involves its partners in relevant control steps within the change process.

DIN EN ISO 9001
DIN EN ISO 13485
ISO 13485 with SCC accreditation (Canada)

FDA registered (21 CFR teil 820 konform)
CSA/UL registered

Company Structure


Diatron


Your Experts in Hematology and Clinical Chemistry

The Diatron business unit develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for human medical and veterinary use. Diatron’s expertise enables STRATEC to develop and produce smaller-scale systems and modules, thus rounding out its portfolio.

Board of Management


Marcus Wolfinger

Chairman,
Board of Management

Function:

Chairman, Board of Management

Place of Birth:

Neuenbürg

Birth Date:

July 27, 1967

Education:

Graduate in business administration

Career at STRATEC:

Joined the company on March 1, 1998 and appointed to Board of Management on July 1, 1999. Chairman of Board of Management since April 1, 2011; appointed until June 15, 2021.

Dr. Robert Siegle

Member, Board of Management
Finances and Human Resources

Function:

Member, Board of Management, Finances and Human Resources

Place of Birth:

Stuttgart

Birth Date:

May 16, 1967

Education:

Attorney

Career at STRATEC:

Member of the Supervisory Board since the company’s conversion to a stock corporation in May 1998; Retirement from Supervisory Board as of December 31, 2010 due to forthcoming appointment to Board of Management; Member of the Board of Management since February 1, 2011; appointed until December 31, 2020.

Dr. Claus Vielsack

Member, Board of Management
Product Development

Function:

Member, Board of Management, Product Development

Place of Birth:

Pforzheim

Birth Date:

August 28, 1967

Education:

Graduate in chemistry

Career at STRATEC:

Joined the company on September 1, 1998, has held various senior product development positions; Member of the Board of Management responsible for product development since February 15, 2014; appointed until December 31, 2018.

Supervisory Board


Fred K. Brückner

Chairman
Supervisory Board

Function:

Chairman, Supervisory Board

Place of Birth:

Arnstadt

Birth Date:

January 30, 1943

Education:

Chemical Engineer

Career at STRATEC:

Member of the Supervisory Board since the company’s conversion into stock corporation in May 1998; Chairman of the Supervisory Board since March 2000; appointed until the end of the AGM releasing the Supervisory Board from responsibility for the 2018 fiscal year.

Rainer Baule

Deputy Chairman
Supervisory Board

Function:

Deputy Chairman, Supervisory Board

Place of Birth:

Wimbern

Birth Date:

October 2, 1948

Education:

Degree in Business Administration and Engineering

Career at STRATEC:

Deputy Chairmain of the Supervisory Board since June 14, 2017; appointed until the end of the AGM releasing the Supervisory Board from responsibility for the 2018 fiscal year.

Prof. Dr. Stefanie Remmele

Member
Supervisory Board

Function:

Member, Supervisory Board

Place of Birth:

Bayreuth

Birth Date:

April 4, 1978

Education:

Graduate in electrical engineering

Career at STRATEC:

Member of the Supervisory Board since June 18, 2014; appointed until the end of the AGM releasing the Supervisory Board from responsibility for the 2018 fiscal year.

History


1979

Founding

Stratec is founded in Birkenfeld, Germany

1987

Medical Systems

First medical systems are developed

1993

New Systems

Systems for bio- and chemi-luminescence and coagulation applications are launched

1996

Automation Platform

Development work on an automation platform for microplate applications commences

1997

Location US

STRATEC Biomedical Inc. is founded in the US

1998

Publicity traded company

STRATEC becomes a publicity traded company

2002

STRATEC NewGen GmbH

STRATEC NewGen GmbH is founded in Birkenfeld, Germany

2005

Robion AG

Robion AG is founded in Switzerland

2006

Sanguin International Ltd.

Acquisition of Sanguin International Ltd. (UK) and its US subsidiary

2008

Location Romania

STRATEC Biomedical Systems S.R.L. is founded in Romania

2009

Invitek

Acquisition of Invitek Gesellschaft für Biotechnik & Biodesign mbH in Berlin, Germany

2010

Ballista Inc.

Acquisition of Ballista Inc. in Newbury Park, California, USA

2013

Location China

STRATEC Biomedical (Taicang) is founded in China

2016

Diatron

Acquisition of Diatron MI PLC, Budapest, Hungary

2016

STRATEC Consumables (Sony DADC BioSciences)

Acquisition of Sony DADC BioSciences, now STRATEC Consumables